Chapy Venkatesan

Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009

Zobair M. Younossi, Munkhzul Otgonsuren, Linda Henry et al. · Hepatology · 2015 · 787 citations

In-Hospital Mortality and Economic Burden Associated With Hepatic Encephalopathy in the United States From 2005 to 2009

Maria Stepanova, Alita Mishra, Chapy Venkatesan et al. · Clinical Gastroenterology and Hepatology · 2012 · 230 citations · Full text

Hepatic Encephalopathy, Hepatology, Health Economics +11

In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not

Zobair M. Younossi, Munkhzul Otgonsuren, Chapy Venkatesan et al. · Metabolism · 2012 · 168 citations

Metabolic Disorder, Fatty Liver Disease, Obesity +16

Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate Coronavirus Disease 2019 (COVID-19): A Real-World Experience

John Paul Verderese, Maria Stepanova, Brian Lam et al. · Clinical Infectious Diseases · 2021 · 84 citations · Full text

Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States

James M. Paik, Pegah Golabi, Rakesh Biswas et al. · Hepatology Communications · 2020 · 79 citations · Full text